Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

FDA approves OTC HIV test; Good Herbs disclaimer does not cancel drug claims; American Herbal Pharmacopoeia releases blue cohosh monograph; salmonella triggers Standard Process supplement recall; Kemin, Ball see zeaxanthin partnership bloom; more In Brief.

You may also be interested in...



New Products In Brief: Salonpas gel, algal protein in CleanSeries, Kemin eye health line, Merck supplies Solgar folate

Salonpas gel targets pain precisely; Twinlab adds algal protein to CleanSeries; ZeaONE expands Kemin eye health line; Merck supplies Solgar folate; Cyvex offers fish-derived protein powder; NeuroScience calming products now dissolvable; Organix-South soothes with neem rub.

New Products In Brief: Salonpas gel, algal protein in CleanSeries, Kemin eye health line, Merck supplies Solgar folate

Salonpas gel targets pain precisely; Twinlab adds algal protein to CleanSeries; ZeaONE expands Kemin eye health line; Merck supplies Solgar folate; Cyvex offers fish-derived protein powder; NeuroScience calming products now dissolvable; Organix-South soothes with neem rub.

In Brief

FDA’s Blumberg dies; Hi-tech sales up, income down; Reliv targets U.S. growth; investigation costs slow Omega Protein; AB Biotics launches AB-Dentis worldwide; Liquid Nutrition franchising reaches U.S.; and Ingredion gets fiber approval in Canada.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105846

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel